Results 31 to 40 of about 2,691 (207)

A case of alcaptonuria with fatal cardiovascular disturbance [PDF]

open access: yes, 1976
A case of alcaptonuria combined with aortic insufficiency was found in a 28-year-old male. The patient was palpitating at admission. The daily excretion of homogentisic acid was 2.0-6.0 g.
Arima, Terukatsu   +6 more
core   +1 more source

Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria [PDF]

open access: yes, 2017
This work was supported by the Medical Research Council (MR/L002876/1), the Royal College of Surgeons of England, Fondazione Telethon Italy (GGP10058), and Associazione Italiana Malati di Alcaptonuria (AimAKU ...
Bernardini   +79 more
core   +1 more source

Exogenous ochronosis

open access: yesDermatology Online Journal, 2008
A 55-year-old woman with melasma develops biopsy-proved exogenous ochronosis in the setting of prolonged topical hydroquinone use. A limited number of similar reports exist in the US literature and are the basis for an FDA call to review hydroquinone-based products.
Merola, Joseph F   +3 more
openaire   +4 more sources

Bilateral Breast Ochronosis: a Case Report

open access: yesJPRAS Open, 2021
: Ochronosis is a syndrome characterized by bluish black discoloration due to the deposition of polymerized products of homogentisic acid (HGA) in the connective tissues.
Fatema A.J. AbdulKarim   +3 more
doaj   +1 more source

Exogenous ochronosis superimposed on chronic kidney disease: A case report and review of literature

open access: yesSahel Medical Journal, 2018
Ochronosis is a rare disease characterized by speckled and diffuse pigmentation symmetrically over the face, neck, and photo-exposed areas. It can present in exogenous or endogenous form.
Ishrat Hussain Dar   +4 more
doaj   +1 more source

Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. [PDF]

open access: yes, 2016
BACKGROUND: Alkaptonuria (AKU) is a serious genetic disease characterised by premature spondyloarthropathy. Homogentisate-lowering therapy is being investigated for AKU.
Andrea Zatkova   +51 more
core   +1 more source

Ochronosis as an unusual cause of valvular defect: a case report

open access: yesJournal of Medical Case Reports, 2009
Introduction Alkaptonuria (also known as ochronosis) is a genetic disorder characterised by the accumulation of homogentisic acid deposits in connective tissue. In rare cases, ochronosis can cause valvular heart disease.
Steverding Dietmar, Wilke Andreas
doaj   +1 more source

Exogenous ochronosis

open access: yesJournal of the American Academy of Dermatology, 2000
Ochronosis is an uncommon condition characterized by yellow-brown pigment deposits in the dermis. It occurs in exogenous and endogenous forms. We report a case of exogenous ochronosis in a Hispanic woman and discuss the different forms of this condition. We treated the lesions with Q-switched ruby laser.
K E, Kramer   +3 more
openaire   +2 more sources

What does the arthropathy of alkaptonuria teach us about disease mechanisms in osteoarthritis and ageing of joints? Lessons from a rare disease [PDF]

open access: yes, 2016
AKU Society, the Rosetrees Foundation, the Childwick Trust, the Big Lottery and ...
Alan Boyde   +4 more
core   +1 more source

Endogenous ochronosis with keratoelastoidosis marginalis

open access: yesIndian Journal of Dermatopathology and Diagnostic Dermatology, 2019
Endogenous ochronosis is a manifestation of alkaptonuria, a rare metabolic disease due to homogentisic acid oxidase deficiency. Darkened urine and arthropathy are the other two components that complete the triad of alkaptonuria. Pigmentation of skin, the
R Mythreyi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy